CI vs MNPR · P/E 2.4, rev $274.90B vs $431.4M cap
Cigna Corp (CI) versus Monopar Therapeutics Inc (MNPR) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported MNPR revenue for 2024-12-31 was $0. Net income was -$15.6M. MNPR currently screens at market cap $431.4M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. MNPR currently screens at market cap $431.4M.
Not investment advice. Open the CI and MNPR stock pages for the full models.
Not investment advice.